Today's Daily Dose brings you news about Applied Genetic's X-linked retinitis pigmentosa trial results, FDA approval of the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors and DBV Tech's long-term data from phase III open-label extension study of Viaskin Peanut, among others.
from RTT - Biotech https://ift.tt/2FBkL0o
via IFTTT
No comments:
Post a Comment